RSO
There has been a lot said about RSO, not a lot of clinical research but that is changing. I’m still seeing questions every week about what RSO is and what it does and how to make it. I had my own questions so I set out to find the answers. One of the first things I did was find out how it is made, basically soak weed in a solvent and then evaporate the solvent and what you have left are the oils that were suspended in the solvent. It gets a lot more complicated but more on that later.
I came into a 180 proof Everclear and filled the bottle with top shelf buds after making a little room in the bottle by sweetening my coffee a few times. After a week of shaking the bottle daily I opened it and poked around with a stick creating general havoc and then set it aside again, shaking it every time I happened to think about it.
After around a Month I had a delightfully tinted alcohol which I put through a silk screen and then set out in a large glass pie plate with a silk screen cover to keep dust out. After some passage of time the alcohol was gone and all that was left was a thick, black tar like substance. RSO!
With no ability to actually test it I have no idea of the potency. From what I have read a dose would be around 1/10th of a gram or one small drop orally, I suppose it could be used as a salve or lotion should one desire.
The best source for basic information about Rick Simpson Oil remains Rick Simpson.
Ricky Logan Simpson (born November 30, 1949), also known as Rick Simpson, has become famous for teaching people that cannabis oil can cure cancer and many other health problems. Some people believe that his claims are unsubstantiated because he bases his statements on personal experience and testimonials. There is not enough scientific evidence at this time to support the claim that cannabis oil can cure all cancers.
He is a retired power engineer who worked for 25 years in the medical system in Canada. After suffering a severe head injury in 1997 that caused him to have chronic pain, high blood pressure and insomnia. He took all the medications that the doctors prescribed, but they did little for him and their side effects did nothing but harm. The medications essentially turned him into a chemical zombie. So in desperation he turned to the use of cannabis extracts, which he produced himself and quickly found that it helped him to such an extent that he started to believe that cannabis may be the greatest natural medicine on earth.
Cannabis oil controlled his pain, his blood pressure and allowed him to sleep. Later on he was diagnosed with skin cancer and his doctor failed to heal it with surgery so he decided to use cannabis oil on it because of a news report that he heard in 1974 about how THC had shrunk cancer tumors. He affirmed that he applied cannabis oil on some bandages and placed the bandages over the areas that had skin cancer and that four days later the cancer was healed. Rick said that he began making the oil and using it to treat and cure dozens of people of different health problems. Eventually thousands of people came to him for cannabis oil treatments and he successfully treated over 5,000 people for free. There is no way to verify if he really healed thousands of people.
After learning the truth about the amazing healing abilities of these extracts, he then went to those in authority to have its use recognized. Instead of support, he found that in reality those in positions of power, wanted to keep the truth hidden from public view. Having no where else to turn, he made this knowledge public by making a website in 2004 called phoenixtears to educate the public and by releasing a free documentary in 2008 on youtube called “Run From the Cure” that shared his story.
You can view Rick’s website at http://phoenixtears.ca/
or visit with Rick on his Facebook Page.
Here is a good video on how to make RSO at home yourself…
Some of the mainstream research can be found at the following links from cbdfarm
- “The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model”
from Molecular Cancer Therapeutics, 2014 - “Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells”
from The Journal of Clinical Investigation, 2009 - “Cannabinoids and gliomas.”
from The Journal of Molecular Neurobiology, 2007 - “A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme”
from British Journal of Cancer, 2006 - “Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism”
from The British Journal of Pharmacology, 2005 - “Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines”
from The Journal of Pharmacology, 2004 - “Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas”
from The Journal of Cancer Research & American Journal of Cancer, 2004 - “Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor”
from The Journal of Cancer Research & American Journal of Cancer, 2001
Breast Cancer
- “Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation”
from Endocrinology, 2013 - “Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration”
from Toxicology Letters, 2012 - “Cannabinoids: a new hope for breast cancer therapy?”
from Cancer Treatment Reviews, 2012 - “Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancergrowth and invasion.”
from PLoS One, 2011 - “Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.”
from Breast Cancer Research & Treatment, 2011 - “Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition”
from Molecular Cancer, 2010 - “Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.”
from Molecular Cancer Therapeutics, 2007 - “Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation”
from Journal of Cancer Research, 2006 - “Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma”
from Journal of Pharmacology, 2006
Lung Cancer
- “Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.”
from The FASEB Journal, 2012 - “Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.”
from Cancer Prevention Research, 2011 - “Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo”
from Oncogene, 2008
Mouth & Throat Cancer
- “Cannabinoids inhibit cellular respiration of human oral cancer cells”
from Pharmacology, 2010
Uterine, Testicular, & Pancreatic Cancer
- “Cannabis and Cannabinoids”
from National Cancer Institute, 2014 - “Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress–Related Genes”
from Cancer Research, 2006
Prostate Cancer
- “The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications”
from Indian Journal of Urology, 2012 - “Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production”
from Prostate, 2003 - Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16INK4a/pRB pathway
from Carcinogenesis 23 (5), 721-725, 2002
Colorectal Cancer
- “Cannabinoids in intestinal inflammation and cancer”
from Pharmacological Research, 2009 - (PDF) “Turned-off Cannabinoid Receptor Turns on Colorectal Tumor Growth”
from The University of Texas MD Anderson Cancer Center, 2008 - “The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2”
from Gut, 2005
Ovarian Cancer
Blood Cancer
- “Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation”
from International Journal of Cancer, 2008 - “Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria”
from Molecular Cancer Research, 2006 - “Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease”
from Blood, 2002
Skin Cancer
- “Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors”
from Journal of Clinical Investigation, 2003
Liver Cancer
- “Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy”
from Cell Death & Differentiation, 2011
Biliary Tract Cancer
- “The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration”
from Cancer Investigations, 2010
Bladder Cancer
- “Marijuana may lower bladder cancer risk”
from American Urological Association, 2013
Overview Articles (All Cancers)
- “Cannabidiol as potential anticancer drug”
from British Journal of Clinical Pharmacology, 2013 - “Cannabinoids as therapeutic agents in cancer: current status and future implications”
from Oncotarget, 2014 - (PDF) “Cannabinoids for Cancer Treatment: Progress and Promise”
from Cancer Research, 2008 - “Inhibition of tumor angiogenesis by cannabinoids”
from The FASEB Journal, 2003
Huntington’s Disease
- “Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB1 and CB2 Receptors”
from ACS Chemical Neuroscience, 2009
Alzheimer’s Disease
- “Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice”
from Journal of Alzheimer’s Disease, 2015
Other Articles
- (PDF) “Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb”
from Cell Press, 2009
Foundational Cannabinoid Research Articles
- (PDF) That which we call Indica, by any other name would smell as sweet
from Cannabinoids 9(1), 9-15, 2014 - Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
from PLoS One 9(3), e89566, 2014 - Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
from British Journal of Pharmacology, 163(7), 1344-1364, 2011 - Gut feelings about the endocannabinoid system
from Neurogastroenterology & Motility, 23 (5) 391–398, 2011 - (PDF) Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
from Biol. Pharm. Bull. 34(5), 774-778, 2011 - Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases
from Journal of Medicinal Chemistry 53(4): 1830–1842, 2010 - (PDF) The endocannabinoid system in targeting inflammatory neurodegenerative diseases
from TRENDS in Pharmacological Sciences 28 (4), 180-187, 2007 - (PDF) The Endocannabinoid System as an Emerging Target of Pharmacotherapy
from Pharmacological Reviews 58(3), 389-462, 2006 - (PDF) Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
from Nature 434, 782-786, 2005 - An Overview of the Endogenous Cannabinoid System: Components and Possible Roles of this Recently Discovered Regulatory System
from Erowid.org, v1.1 May 2003, v1.2 Feb 2005 - Letters to Nature: Leptin-regulated endocannabinoids are involved in maintaining food intake
from Nature 410, 822-825, 2001